Later onset of menstruation, menopause may be associated with longer life
Women who start menstruation and experience menopause later in life may have increased chances of living to be 90, according to a study in…
Women’s Health
Secondary postpartum hemorrhage: Risk factors, assessment, and intervention
Jayne Kennedy, a 35-year-old, gravida 2, para 2, is admitted to the emergency department with heavy vaginal bleeding. Two weeks earlier, she’d delivered an…
Preventative treatment for adult survivors of sexual assault
A 21-year-old woman arrives for a scheduled annual well-woman exam at the local family planning clinic where you work. She tells you that 2…
Prescribed opioids among pregnant women may have contributed to increase in neonatal abstinence syndrome
The increase in use of prescribed opioids among women during pregnancy has probably contributed to the rise in neonatal abstinence syndrome, according to an…
Wrist fractures may predict more serious fractures in postmenopausal women
Wrist fractures among women younger than 65 may predict more serious fractures in other parts of their bodies later in life, according to a…
Good night, baby…sleep safely
For more than 20 years, the American Academy of Pediatrics (AAP) has encouraged everyone to place infants on their backs to sleep to help…
WHO issues new HIV treatment recommendations
According to a new guideline from the World Health Organization (WHO), anyone infected with HIV should begin antiretroviral treatment as soon after diagnosis as…
FDA approves drug for sexual desires disorders in women
On Aug. 18, the U.S. Food and Drug Administration (FDA) approved Addyi (flibanserin) to treat acquired, generalized hypoactive sexual desire disorder in premenopausal women.…
Sexual assault screening in the outpatient setting
Every 2 minutes, someone in the United States experiences a sexual assault. Sexual assault encompasses a number of acts ranging from inappropriate exposure or…
FDA approves Ibrance for postmenopausal women with metastatic breast cancer
On February 3, the U.S. Food and Drug Administration (FDA) approved Ibrance (palbociclib) to treat advanced metastatic breast cancer. Read more.
Later onset of menstruation, menopause may be associated with longer life
Women who start menstruation and experience menopause later in life may have increased chances of living to be 90, according to a…
Secondary postpartum hemorrhage: Risk factors, assessment, and intervention
Jayne Kennedy, a 35-year-old, gravida 2, para 2, is admitted to the emergency department with heavy vaginal bleeding. Two weeks earlier, she’d…
Preventative treatment for adult survivors of sexual assault
A 21-year-old woman arrives for a scheduled annual well-woman exam at the local family planning clinic where you work. She tells you…
Prescribed opioids among pregnant women may have contributed to increase in neonatal abstinence syndrome
The increase in use of prescribed opioids among women during pregnancy has probably contributed to the rise in neonatal abstinence syndrome, according…
Wrist fractures may predict more serious fractures in postmenopausal women
Wrist fractures among women younger than 65 may predict more serious fractures in other parts of their bodies later in life, according…
Good night, baby…sleep safely
For more than 20 years, the American Academy of Pediatrics (AAP) has encouraged everyone to place infants on their backs to sleep…
WHO issues new HIV treatment recommendations
According to a new guideline from the World Health Organization (WHO), anyone infected with HIV should begin antiretroviral treatment as soon after…
FDA approves drug for sexual desires disorders in women
On Aug. 18, the U.S. Food and Drug Administration (FDA) approved Addyi (flibanserin) to treat acquired, generalized hypoactive sexual desire disorder in…
Sexual assault screening in the outpatient setting
Every 2 minutes, someone in the United States experiences a sexual assault. Sexual assault encompasses a number of acts ranging from inappropriate…
FDA approves Ibrance for postmenopausal women with metastatic breast cancer
On February 3, the U.S. Food and Drug Administration (FDA) approved Ibrance (palbociclib) to treat advanced metastatic breast cancer. Read more.
Test Your Knowledge
Emotional Intel TYK
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.